Gender Disparities in Ocular Inflammatory Disorders*

REFERENCES

• Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology 2004;111:491–500
   PubMed Web of Science ®Google Scholar
• Tedeschi SK, Bermas B, Costenbader KH. Sexual disparities in the incidence and course of SLE and RA. Clin Immunol 2013;149:211–218
   PubMed Web of Science ®Google Scholar
• Wilder RL. Adrenal and gonadal steroid hormone deficiency in the pathogenesis of rheumatoid arthritis. J Rheumatol Suppl 1996;44:10–12
   PubMedGoogle Scholar
• Cohen-Solal JF, Jeganathan V, Hill L, Kawabata D, Rodriguez-Pinto D, Grimaldi C, et al. Hormonal regulation of B-cell function and systemic lupus erythematosus. Lupus 2008;17:528–532
   PubMed Web of Science ®Google Scholar
• Waite JC, Skokos D. Th17 response and inflammatory autoimmune diseases. Int J Inflamm 2012;2012:819467
   PubMedGoogle Scholar
• Chiam NP, Hall AJ, Stawell RJ, Busija L, Lim LL. The course of uveitis in pregnancy and postpartum. Br J Ophthalmol 2013;97:1284–1288
   PubMed Web of Science ®Google Scholar
• Kump LI, Cervantes-Castañeda RA, Androudi SN, Foster CS, Christen WG. Patterns of exacerbations of chronic non-infectious uveitis in pregnancy and puerperium. 7. Ocul Immunol Inflamm 2006;14:99–104
   PubMed Web of Science ®Google Scholar
• Sivaraj RR, Durrani OM, Denniston AK, Murray PI, Gordon C. Ocular manifestations of systemic lupus erythematosus. Rheumatology (Oxford) 2007;46:1757–1762 . Review
   PubMed Web of Science ®Google Scholar
• Snyers B, Lambert M, Hardy JP. Retinal and choroidal vaso-occlusive disease in systemic lupus erythematosus associated with antiphospholipid antibodies. Retina 1990;10:255–260
   PubMed Web of Science ®Google Scholar
• Sitaula R, Shah DN, Singh D. The spectrum of ocular involvement in systemic lupus erythematosus in a tertiary eye care center in Nepal. Ocul Immunol Inflamm 2011;19:422–425
   PubMed Web of Science ®Google Scholar
• Lahita RG. The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol 1999;11:352–356
   PubMedGoogle Scholar
• Costenbader KH, Feskanich D, Stampfer MJ, Karlson EW. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum 2007;56:1251–1262
   PubMed Web of Science ®Google Scholar
• Bernier MO, Mikaeloff Y, Hudson M, Suissa S. Combined oral contraceptive use and the risk of systemic lupus erythematosus. Arthritis Rheum 2009;61:476–481
   PubMed Web of Science ®Google Scholar
• Buyon JP, Petri MA, Kim MY, Kalunian KC, Grossman J, Hahn BH, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 2005;142(Pt 1):953–962
   Google Scholar
• Crosbie D, Black C, McIntyre L, Royle PL, Thomas S. Dehydroepiandrosterone for systemic lupus erythematosus. Cochrane Database Syst Rev 2007:CD005114
   Google Scholar
• Alvarez-Nemegyei J, Cobarrubias-Cobos A, Escalante-Triay F, Sosa-Muñoz J, Miranda JM, Jara LJ. Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study. Lupus 1998;7:414–419
   PubMed Web of Science ®Google Scholar
• Lu Q, Wu A, Tesmer L, Ray D, Yousif N, Richardson B. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J Immunol 2007;179:6352–6358
   PubMed Web of Science ®Google Scholar
• Liu J, Zhao Y, Song Y, Zhang W, Bian X, Yang J, et al. Pregnancy in women with systemic lupus erythematosus: a retrospective study of 111 pregnancies in Chinese women. J Matern Fetal Neonatal Med 2012;25:261–266
   PubMed Web of Science ®Google Scholar
• Ateka-Barrutia O, Khamashta MA. The challenge of pregnancy for patients with SLE. Lupus 2013;22:1295–1308
   PubMed Web of Science ®Google Scholar
• Takala JH, Kautiainen H, Leirisalo-Repo M. Survival of patients with Wegener's granulomatosis diagnosed in Finland in 1981–2000. Scand J Rheumatol 2010;39:71–76
   PubMed Web of Science ®Google Scholar
• Tarabishy AB, Schulte M, Papaliodis GN, Hoffman GS. Wegener's granulomatosis: clinical manifestations, differential diagnosis, and management of ocular and systemic disease. Surv Ophthalmol 2010;55:429–444
   PubMed Web of Science ®Google Scholar
• Karlson EW, Mandl LA, Hankinson SE, Grodstein F. Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study. Arthritis Rheum 2004;50:3458–3467
   PubMed Web of Science ®Google Scholar
• Nelson JL, Ostensen M. Pregnancy and rheumatoid arthritis. Rheum Dis Clin North Am 1997;23:195–212
   PubMed Web of Science ®Google Scholar
• Cutolo M. Androgens in rheumatoid arthritis: when are they effectors? Arthritis Res Ther 2009;11:126
   PubMedGoogle Scholar
• Hall GM, Daniels M, Huskisson EC, Spector TD. A randomised controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis. Ann Rheum Dis 1994;53:112–116
   PubMed Web of Science ®Google Scholar
• Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998;25:1991–1994
   PubMedGoogle Scholar
• Heiligenhaus A, Heinz C, Edelsten C, Kotaniemi K, Minden K. Review for disease of the year: epidemiology of juvenile idiopathic arthritis and its associated uveitis: the probable risk factors. Ocul Immunol Inflamm 2013;21:180–191
   PubMed Web of Science ®Google Scholar
• Carvounis PE, Herman DC, Cha S, Burke JP. Incidence and outcomes of uveitis in juvenile rheumatoid arthritis, a synthesis of the literature. Graefes Arch Clin Exp Ophthalmol 2006;244:281–290
   PubMed Web of Science ®Google Scholar
• Saurenmann RK, Rose JB, Tyrrell P, Feldman BM, Laxer RM, Schneider R, et al. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor. Arthritis Rheum 2007;56:1974–1984
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Niewerth M, Ganser G, Heinz C, Minden K; German Uveitis in Childhood Study Group. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology (Oxford) 2007;46:1015–1019
   PubMed Web of Science ®Google Scholar
• Saurenmann RK, Levin AV, Feldman BM, Laxer RM, Schneider R, Silverman ED. Risk factors for development of uveitis differ between girls and boys with juvenile idiopathic arthritis. Arthritis Rheum 2010;62:1824–1828
   PubMedGoogle Scholar
• Kalinina Ayuso V, Ten Cate HA, van der Does P, Rothova A, de Boer JH. Male gender as a risk factor for complications in uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol 2010;149:994–999 .e5
   PubMed Web of Science ®Google Scholar
• Thomas KW, Hunninghake GW. Sarcoidosis. JAMA 2003;289:3300–3303
   PubMed Web of Science ®Google Scholar
• Hillerdal G, Nöu E, Osterman K, Schmekel B. Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis 1984;130:29–32
   PubMed Web of Science ®Google Scholar
• Jørgensen KT, Pedersen BV, Nielsen NM, Jacobsen S, Frisch M. Childbirths and risk of female predominant and other autoimmune diseases in a population-based Danish cohort. J Autoimmun 2012;38:J81–J87
   Google Scholar
• Umur KA, Tayfun B, Oguzhan O. Different ophthalmologic manifestations of sarcoidosis. Curr Opin Ophthalmol 2012;23:477–484
   PubMed Web of Science ®Google Scholar
• Birnbaum AD, Oh FS, Chakrabarti A, Tessler HH, Goldstein DA. Clinical features and diagnostic evaluation of biopsy-proven ocular sarcoidosis. Arch Ophthalmol 2011;129:409–413
   PubMedGoogle Scholar
• Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr, Bresnitz EA, et al. Case Control Etiologic Study of Sarcoidosis (ACCESS) research group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001;164(Pt 1):1885–1889
   Google Scholar
• Lobo A, Barton K, Minassian D, du Bois RM, Lightman S. Visual loss in sarcoid-related uveitis. Clin Experiment Ophthalmol 2003;31:310–316
   PubMed Web of Science ®Google Scholar
• Wakefield D, Chang JH, Amjadi S, Maconochie Z, Abu El-Asrar A, McCluskey P. What is new HLA-B27 acute anterior uveitis? Ocul Immunol Inflamm 2011;19:139–144
   PubMed Web of Science ®Google Scholar
• Lee W, Reveille JD, Weisman MH. Women with ankylosing spondylitis: a review. Arthritis Rheum 2008;59:449–454
   PubMed Web of Science ®Google Scholar
• Niederer R, Danesh-Meyer H. Uveitis screening: HLAB27 antigen and ankylosing spondylitis in a New Zealand population. N Z Med J 2006;119:U1886
   PubMedGoogle Scholar
• Torres S, Borges S, Artiles A. HLA-B27 and clinical features of acute anterior uveitis in Cuba. Ocul Immunol Inflamm 2013;21:119–123
   PubMed Web of Science ®Google Scholar
• Zheng MQ, Wang YQ, Lu XY, Wang YL, Mao LP, Gu YF, et al. Clinical Analysis of 240 Patients with HLA-B27 Associated Acute Anterior Uveitis. Yan Ke Xue Bao 2012;27:169–172
   Google Scholar
• Loh AR, Acharya NR. Incidence rates and risk factors for ocular complications and vision loss in HLA-B27-associated uveitis. Am J Ophthalmol 2010;150:534–542 .e2
   PubMed Web of Science ®Google Scholar
• Braakenburg AM, de Valk HW, de Boer J, Rothova A. Human leukocyte antigen-B27-associated uveitis: long-term follow-up and gender differences. Am J Ophthalmol 2008;145:472–479
   PubMed Web of Science ®Google Scholar
• Miayamoto N, Mandai M, Suzuma I, Suzuma K, Kobayashi K, Honda Y. Estrogen protects against cellular infi ltration by reducing the expressions of E-selectin and IL-6 in endotoxin-induced uveitis. J Immunol 1999;163:374–379
   Google Scholar
• Braun J, Kingsley G, van der Heijde D, Sieper J. On the difficulties of establishing a consensus on the definition of and diagnostic investigations for reactive arthritis. Results and discussion of a questionnaire prepared for the 4th International Workshop on Reactive Arthritis, Berlin, Germany, July 3–6, 1999. J Rheumatol 2000;27:2185–2192
   PubMed Web of Science ®Google Scholar
• Sampaio-Barros PD, Bortoluzzo AB, Conde RA, Costallat LT, Samara AM, Bértolo MB. Undifferentiated spondyloarthritis: a longterm followup. J Rheumatol 2010;37:1195–1199
   PubMed Web of Science ®Google Scholar
• Brockbank J, Gladman D. Diagnosis and management of psoriatic arthritis. Drugs 2002;62:2447–2457
   PubMed Web of Science ®Google Scholar
• Munkholm P, Langholz E, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962–1987: a sixfold increase in incidence. Scand J Gastroenterol 1992;27:609–614
   PubMed Web of Science ®Google Scholar
• Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Ulcerative colitis in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival. Gut 2000;46:336–343
   PubMed Web of Science ®Google Scholar
• American Academy of Ophthalmology. Basic and clinical science course. Intraocular Inflammation and Uveitis. Section 9 2013–2014; pp 120–123
   Google Scholar
• Farhi D, Cosnes J, Zizi N, Chosidow O, Seksik P, Beaugerie L, et al. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients. Medicine (Baltimore) 2008;87:281–293
   PubMed Web of Science ®Google Scholar
• Gül A. Behçet's disease: an update on the pathogenesis. Clin Exp Rheumatol 2001;19(Suppl 24):S6–S12
   Google Scholar
• Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR. Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 1999;54:213–220
   PubMedGoogle Scholar
• Gül A. Behçet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 2005;4:81–83
   PubMedGoogle Scholar
• Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet 1990;335:1078–1080
   PubMed Web of Science ®Google Scholar
• Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M, et al. Behcet's disease: from East to West. Clin Rheumatol 2010;29:823–833
   PubMed Web of Science ®Google Scholar
• Mahr A, Belarbi L, Wechsler B, Jeanneret D, Dhote R, Fain O, et al. Population-based prevalence study of Behçet's disease: differences by ethnic origin and low variation by age at immigration. Arthritis Rheum 2008;58:3951–3959
   PubMed Web of Science ®Google Scholar
• Calamia KT, Wilson FC, Icen M, Crowson CS, Gabriel SE, Kremers HM. Epidemiology and clinical characteristics of Behçet's disease in the US: a population-based study. Arthritis Rheum 2009;61:600–604
   PubMed Web of Science ®Google Scholar
• Soheilian M, Heidari K, Yazdani S, Shahsavari M, Ahmadieh H, Dehghan M. Patterns of uveitis in a tertiary eye care center in Iran. Ocul Immunol Inflamm 2004;12:297–310
   PubMed Web of Science ®Google Scholar
• Wang LY, Zhao DB, Gu J, Dai SM. Clinical characteristics of Behçet's disease in China. Rheumatol Int 2010;30:1191–1196
   PubMed Web of Science ®Google Scholar
• See LC, Kuo CF, Chou IJ, Chiou MJ, Yu KH. Sex- and age-specific incidence of autoimmune rheumatic diseases in the Chinese population: a Taiwan population-based study. Semin Arthritis Rheum 2013;43:381–386
   PubMed Web of Science ®Google Scholar
• Saleh OA, Birnbaum AD, Tessler HH, Goldstein DA. Behçet uveitis in the American midwest. Ocul Immunol Inflamm 2012;20:12–17
   PubMed Web of Science ®Google Scholar
• Alpsoy E, Zouboulis CC, Ehrlich GE. Mucocutaneous lesions of Behcet's disease. Yonsei Med J 2007;48:573–585
   PubMed Web of Science ®Google Scholar
• Seyahi E, Yazici H. Prognosis in Behcet's Syndrome. In: Yazici Y, Yazici H, editors. Behcet's syndrome. New York: Springer; 2010. pp 285–295
   Google Scholar
• Cho YJ, Kim WK, Lee JH, Byeon SH, Koh HJ, Kwon OW, et al. Visual prognosis and risk factors for korean patients with behcet uveitis. Ophthalmologica 2008;222:344–350
   Google Scholar
• Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, et al. The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 2003;82:60–76
   PubMed Web of Science ®Google Scholar
• Krause L, Köhler AK, Altenburg A, Papoutsis N, Zouboulis CC, Pleyer U, et al. Ocular involvement in Adamantiades-Behçet's disease in Berlin, Germany. Graefes Arch Clin Exp Ophthalmol 2009;247:661–666
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Urgancioglu M. Childhood-onset uveitis in Behçet disease:a descriptive study of 36 cases. Am J Ophthalmol 2003;136:1114–1119
   PubMed Web of Science ®Google Scholar
• Matsuo T, Itami M. Recurrent versus non-recurrent or no eye involvement in Behcet's disease. Ocul Immunol Inflamm 2005;13:73–77
   PubMed Web of Science ®Google Scholar
• Wakefield D, Cunningham ET Jr, Tugal-Tutkun I, Khairallah M, Ohno S, Zierhut M. Controversies in Behçet disease. Ocul Immunol Inflamm 2012;20:6–11
   PubMed Web of Science ®Google Scholar
• Simpson S Jr, Blizzard L, Otahal P, Van der Mei I, Taylor B. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry 2011;82:1132–1141
   PubMed Web of Science ®Google Scholar
• Koch-Henriksen N, Sørensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 2010;9:520–532
   PubMed Web of Science ®Google Scholar
• Compston A, Coles A. Multiple sclerosis. Lancet 2002;359:1221–1231
   PubMed Web of Science ®Google Scholar
• Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: noninfectious factors. Ann Neurol 2007;61:504–513
   PubMed Web of Science ®Google Scholar
• Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 2007;61:288–299
   PubMed Web of Science ®Google Scholar
• International Multiple Sclerosis Genetics Consortium, Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL, et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007;357:851–862
   PubMed Web of Science ®Google Scholar
• Lundmark F, Duvefelt K, Iacobaeus E, Kockum I, Wallström E, Khademi M, et al. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet 2007;39:1108–1113
   PubMed Web of Science ®Google Scholar
• Dua T, Rompani P. Atlas: multiple sclerosis resources in the world, 2008. Geneva, Switzerland: World Health Organization; 2008
   Google Scholar
• Compston A, Confavreux C, Lassmann H, McDonald I, Miller D, Noseworthy J, et al. McAlpine's multiple sclerosis. 4th ed. Philadelphia: Churchill Livingstone/Elsevier; 2006. pp 113–272
   Google Scholar
• Tintoré M, Arrambide G. Early onset multiple sclerosis: the role of gender. J Neurol Sci 2009;15;286 :31–34
   Google Scholar
• Alonso A, Hernán MA. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 2008;71:129–135
   PubMed Web of Science ®Google Scholar
• Kotzamani D, Panou T, Mastorodemos V, Tzagournissakis M, Nikolakaki H, Spanaki C, et al. Rising incidence of multiple sclerosis in females associated with urbanization. Neurology 2012;78:1728–1735
   PubMed Web of Science ®Google Scholar
• Simone IL, Carrara D, Tortorella C, Liguori M, Lepore V, Pellegrini F, et al. Course and prognosis in early-onset MS: comparison with adult-onset forms. Neurology 2002;59:1922–1928
   PubMed Web of Science ®Google Scholar
• Lević ZM, Dujmović I, Pekmezović T, Jarebinski M, Marinković J, Stojsavljević N, et al. Prognostic factors for survival in multiple sclerosis. Mult Scler 1999;5:171–178
   PubMedGoogle Scholar
• Bergamaschi R. Prognostic factors in multiple sclerosis. Int Rev Neurobiol 2007;79:423–447
   PubMed Web of Science ®Google Scholar
• Tremlett H, Devonshire V. Is late-onset multiple sclerosis associated with a worse outcome? Neurology 2006;67:954–959
   Google Scholar
• D'hooghe MB, D'Hooghe T, De Keyser J. Female gender and reproductive factors affecting risk, relapses and progression in multiple sclerosis. Gynecol Obstet Invest 2013;75:73–84
   PubMed Web of Science ®Google Scholar
• Smith-Bouvier DL, Divekar AA, Sasidhar M, Du S, Tiwari-Woodruff SK, King JK, et al. A role for sex chromosome complement in the female bias in autoimmune disease. J Exp Med 2008;205:1099–1108
   PubMed Web of Science ®Google Scholar
• Zein G, Berta A, Foster CS. Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm 2004;12:137–142
   PubMed Web of Science ®Google Scholar
• Chen L, Gordon LK. Ocular manifestations of multiple sclerosis. Curr Opin Ophthalmol 2005;16:315–320
   PubMedGoogle Scholar
• Le Scanff J, Sève P, Renoux C, Broussolle C, Confavreux C, Vukusic S. Uveitis associated with multiple sclerosis. Mult Scler 2008;14:415–417
   PubMed Web of Science ®Google Scholar
• Raja SC, Jabs DA, Dunn JP, Fekrat S, Machan CH, Marsh MJ, et al. Pars planitis: clinical features and class II HLA associations. Ophthalmology 1999;106:594–599
   PubMed Web of Science ®Google Scholar
• Biousse V, Trichet C, Bloch-Michel E, Roullet E. Multiple sclerosis associated with uveitis in two large clinic-based series. Neurology 1999;52:179–181
   PubMed Web of Science ®Google Scholar
• Li SY, Birnbaum AD, Goldstein DA. Optic neuritis associated with adalimumab in the treatment of uveitis. Ocul Immunol Inflamm 2010;18:475–481
   PubMed Web of Science ®Google Scholar
• Bordaberry MF. Vogt-Koyanagi-Harada disease: diagnosis and treatments update. Curr Opin Ophthalmol 2010;21:430–435
   PubMed Web of Science ®Google Scholar
• Yodmuang T, Rothova A, Kunavisarut P, Pathanapitoon K. Vogt-Koyanagi-Harada disease in Thailand. Ocul Immunol Inflamm 2012;20:419–422
   PubMed Web of Science ®Google Scholar
• Aláez C, Flores-A H, Concha del Río LE, Munguía A, Rodríguez A, García D, et al. Major histocompatibility complex and strong human leukocyte antigen-DRB1 and gender association with Vogt-Koyanagi-Harada syndrome in Mexican Mestizos. Hum Immunol 2011;72:1198–1203
   PubMed Web of Science ®Google Scholar
• Chee SP, Jap A, Bascal K. Spectrum of Vogt-Koyanagi-Harada disease in Singapore. Int Ophthalmol 2007;27:137–142
   PubMedGoogle Scholar
• Fang W, Yang P. Vogt-koyanagi-harada syndrome. Curr Eye Res 2008;33:517–523
   PubMed Web of Science ®Google Scholar
• Damico FM, Kiss S, Young LH. Vogt-Koyanagi-Harada disease. Semin Ophthalmol 2005;20:183–190
   PubMedGoogle Scholar
• Concha del Río LE, Arellanes-García L. Vogt-Koyanagi-Harada disease in the developing world. Int Ophthalmol Clin 2010;50:189–199
   Google Scholar
• Read RW, Rao NA, Cunningham ET. Vogt-Koyanagi-Harada disease. Curr Opin Ophthalmol 2000;11:437–442
   PubMedGoogle Scholar
• Sen HN, Nussenblatt RB. Sympathetic ophthalmia: what have we learned? Am J Ophthalmol 2009;148:632–633
   PubMed Web of Science ®Google Scholar
• Kilmartin DJ, Wilson D, Liversidge J, Dick AD, Bruce J, Acheson RW, et al. Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients. Br J Ophthalmol 2001;85:281–286
   PubMed Web of Science ®Google Scholar
• Davis JL, Mittal KK, Freidlin V, Mellow SR, Optican DC, Palestine AG, et al. HLA associations and ancestry in Vogt-Koyanagi-Harada disease and sympathetic ophthalmia. Ophthalmology 1990;97:1137–1142
   PubMed Web of Science ®Google Scholar
• Marak GE Jr. Recent advances in sympathetic ophthalmia. Surv Ophthalmol 1979;24:141–156
   PubMed Web of Science ®Google Scholar
• Damico FM, Kiss S, Young LH. Sympathetic ophthalmia. Semin Ophthalmol 2005;20:191–197
   PubMedGoogle Scholar
• Liddy L, Stuart J. Sympathetic ophthalmia in Canada. Can J Ophthalmol 1972;7:157–159
   PubMed Web of Science ®Google Scholar
• Albert DM, Diaz-Rohena R. A historical review of sympathetic ophthalmia and its epidemiology. Surv Ophthalmol 1989;34:1–14
   PubMed Web of Science ®Google Scholar
• Chan CC, Roberge RG, Whitcup SM, Nussenblatt RB. 32 cases of sympathetic ophthalmia. A retrospective study at the National Eye Institute, Bethesda, Md., from 1982 to 1992. Arch Ophthalmol 1995;113:597–600
   PubMedGoogle Scholar
• Galor A, Davis JL, Flynn HW Jr, Feuer WJ, Dubovy SR, Setlur V, et al. Sympathetic ophthalmia: incidence of ocular complications and vision loss in the sympathizing eye. Am J Ophthalmol 2009;148:704–710 .e2
   PubMed Web of Science ®Google Scholar
• Castiblanco CP, Adelman RA. Sympathetic ophthalmia. Graefes Arch Clin Exp Ophthalmol 2009;247:289–302
   PubMed Web of Science ®Google Scholar
• American Academy of Ophthalmology. Basic and Clinical Science Course. Intraocular Inflammation and Uveitis. Section 9 2013–2014, pp 147–172
   Google Scholar
• Abu-Yaghi NE, Hartono SP, Hodge DO, Pulido JS, Bakri SJ. White dot syndromes: a 20-year study of incidence, clinical features, and outcomes. Ocul Immunol Inflamm 2011;19:426–430
   PubMed Web of Science ®Google Scholar
• Heath JD, Spalton DJ. Acute posterior multifocal placoid pigment epitheliopathy. Int Ophthalmol Clin 1995;35:93–105
   Google Scholar
• Gass JD. Acute posterior multifocal placoid pigment epitheliopathy. Arch Ophthalmol 1968;80:177–185
   PubMedGoogle Scholar
• Abrez H, Biswas J, Sudharshan S. Clinical profile, treatment, and visual outcome of serpiginous choroiditis. Ocul Immunol Inflamm 2007;15:325–335
   PubMed Web of Science ®Google Scholar
• Jumper JM, McDonald R, Johnson RN, Ai E, Fu AD. Serpiginous choroiditis. In: Ryan SJ, editor. Retina, Vol. 2, chapter 105. St Louis, MO: Elsevier Mosby; 2006. pp 1811–1820
   Google Scholar
• dell'Omo R, Pavesio CE. Multiple evanescent white dot syndrome (MEWDS). Int Ophthalmol Clin 2012;52:221–228
   PubMedGoogle Scholar
• Borruat FX, Herbort CP, Spertini F, Desarnaulds AB. HLA typing in patients with multiple evanescent white dot syndrome (MEWDS). Ocul Immunol Inflamm 1998;6:39–41
   Web of Science ®Google Scholar
• Shah KH, Levinson RD, Yu F, Goldhardt R, Gordon LK, Gonzales CR, et al. Birdshot chorioretinopathy. Surv Ophthalmol 2005;50:519–541
   PubMed Web of Science ®Google Scholar
• Gass JD. Acute zonal occult outer retinopathy. Donders Lecture: The Netherlands Ophthalmological Society, Maastricht, Holland, June 19, 1992. J Clin Neuroophthalmol 1993;13:79–97
   PubMedGoogle Scholar
• Folk JC, Walker JD. Multifocal choroiditis with panuveitis, diffuse subretinal fibrosis, and punctate inner choroidopathy. In: Ryan SJ, editor. Retina, 4th ed. USA: Elsevier Mosby; 2006. pp 1771–1783
   Google Scholar
• Gerstenblith AT, Thorne JE, Sobrin L, Do DV, Shah SM, Foster CS, et al. Punctate inner choroidopathy: a survey analysis of 77 persons. Ophthalmology 2007;114:1201–1204
   PubMed Web of Science ®Google Scholar
• Dobrin RS, Vernier RL, Fish AL. Acute eosinophilic interstitial nephritis and renal failure with bone marrow-lymph node granulomas and anterior uveitis. A new syndrome. Am J Med 1975;59:325–333
   PubMed Web of Science ®Google Scholar
• Mackensen F, Billing H. Tubulointerstitial nephritis and uveitis syndrome. Curr Opin Ophthalmol 2009;20:525–531
   PubMed Web of Science ®Google Scholar
• Mandeville JT, Levinson RD, Holland GN. The tubulointerstitial nephritis and uveitis syndrome. Surv Ophthalmol 2001;46:195–208
   PubMed Web of Science ®Google Scholar
• Klein SL. The effects of hormones on sex differences in infection: from genes to behavior. Neurosci Biobehav Rev 2000;24:627–638
   PubMed Web of Science ®Google Scholar
• Tucker JD, Li JZ, Robbins GK, Davis BT, Lobo AM, Kunkel J, et al. Ocular syphilis among HIV-infected patients: a systematic analysis of the literature. Sex Transm Infect 2011;87:4–8
   PubMed Web of Science ®Google Scholar
• Yang P, Zhang N, Li F, Chen Y, Kijlstra A. Ocular manifestations of syphilitic uveitis in Chinese patients. Retina 2012;32:1906–1914
   PubMed Web of Science ®Google Scholar
• Eandi CM, Neri P, Adelman RA, Yannuzzi LA, Cunningham ET Jr. International Syphilis Study Group. Acute syphilitic posterior placoid chorioretinitis: report of a case series and comprehensive review of the literature. Retina 2012;32:1915–1941
   PubMed Web of Science ®Google Scholar
• Staras SA, Flanders WD, Dollard SC, Pass RF, McGowan JE Jr, Cannon MJ. Influence of sexual activity on cytomegalovirus seroprevalence in the United States, 1988–1994. Sex Transm Dis 2008;35:472–479
   PubMed Web of Science ®Google Scholar
• Farizo KM, Buehler JW, Chamberland ME, Whyte BM, Froelicher ES, Hopkins SG, et al. Spectrum of disease in persons with human immunodeficiency virus infection in the United States. JAMA 1992;267:1798–1805
   PubMed Web of Science ®Google Scholar
• Jabs DA, Van Natta ML, Kempen JH, Reed Pavan P, Lim JI, Murphy RL, et al. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol 2002;133:48–61
   PubMed Web of Science ®Google Scholar
• Carael M, Marais H, Polsky J, Mendoza A. Is there a gender gap in the HIV response? Evaluating national HIV responses from the United Nations General Assembly Special Session on HIV/AIDS country reports. J Acquir Immune Defic Syndr 2009;52(Suppl 2):S111–S118
   PubMed Web of Science ®Google Scholar
• Sugar EA, Jabs DA, Ahuja A, Thorne JE, Danis RP, Meinert CL; Studies of the Ocular Complications of AIDS Research Group. Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol 2012;153:1016–1024
   PubMed Web of Science ®Google Scholar
• Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ. Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clin Infect Dis 2006;43:1143–1151
   PubMed Web of Science ®Google Scholar
• Fleming PL, Ciesielski CA, Byers RH, Castro KG, Berkelman RL. Gender differences in reported AIDS-indicative diagnoses. J Infect Dis 1993;168:61–67
   PubMed Web of Science ®Google Scholar
• Gangaputra S, Drye L, Vaidya V, Thorne JE, Jabs DA, Lyon AT; Studies of the Ocular Complications of AIDS (SOCA) Research Group. Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 2013;155:206–212 .e5
   Google Scholar
• Tugal-Tutkun I, Otük-Yasar B, Altinkurt E. Clinical features and prognosis of herpetic anterior uveitis: a retrospective study of 111 cases. Int Ophthalmol 2010;30:559–565
   PubMedGoogle Scholar
• Borkar DS, Tham VM, Esterberg E, Ray KJ, Vinoya AC, Parker JV, et al. Incidence of herpes zoster ophthalmicus: results from the Pacific Ocular Inflammation Study. Ophthalmology 2013;120:451–456
   PubMed Web of Science ®Google Scholar
• Al-Mansour YS, Al-Rajhi AA, Al-Dhibi H, Abu El-Asrar AM. Clinical features and prognostic factors in Fuchs' uveitis. Int Ophthalmol 2010;30:501–509
   PubMedGoogle Scholar
• Yang P, Fang W, Jin H, Li B, Chen X, Kijlstra A. Clinical features of Chinese patients with Fuchs' syndrome. Ophthalmology 2006;113:473–480
   PubMed Web of Science ®Google Scholar
• Silva RA, Berrocal AM, Moshfeghi DM, Blumenkranz MS, Sanislo S, Davis JL. Herpes simplex virus type 2 mediated acute retinal necrosis in a pediatric population: case series and review. Graefes Arch Clin Exp Ophthalmol 2013;251:559–566
   PubMed Web of Science ®Google Scholar
• Cannon MJ. Congenital cytomegalovirus (CMV) epidemiology and awareness. J Clin Virol 2009;46(Suppl 4):S6–S10
   PubMed Web of Science ®Google Scholar
• Ghekiere S, Allegaert K, Cossey V, Van Ranst M, Cassiman C, Casteels I. Ophthalmological findings in congenital cytomegalovirus infection: when to screen, when to treat? J Pediatr Ophthalmol Strabismus 2012;49:274–282
   PubMed Web of Science ®Google Scholar
• Coors LE, Spencer R. Delayed presentation of cytomegalovirus retinitis in an infant with severe congenital cytomegalovirus infection. Retina 2010;30(4 Suppl):S59–S62
   Google Scholar
• Noble AG, Latkany P, Kusmierczyk J, Mets M, Rabiah P, Boyer K, et al.; the Toxoplasmosis Study Group. Chorioretinal lesions in mothers of children with congenital toxoplasmosis in the National Collaborative Chicago-based, Congenital Toxoplasmosis Study. Sci Med (Porto Alegre) 2010;20:20–26
   Google Scholar
• Brézin AP, Thulliez P, Couvreur J, Nobré R, Mcleod R, Mets MB. Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis. Am J Ophthalmol 2003;135:779–784
   PubMed Web of Science ®Google Scholar
• Garcia-Méric P, Franck J, Dumon H, Piarroux R. Management of congenital toxoplasmosis in France: current data. Presse Med 2010;39:530–538
   Google Scholar
• Phan L, Kasza K, Jalbrzikowski J, Noble AG, Latkany P, Kuo A, et al.; Toxoplasmosis Study Group. Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life. Am J Ophthalmol 2008;146:375–384
   PubMed Web of Science ®Google Scholar